Yi Sang 4

What Happened
Yi Sang, Group President, Asia Pacific for Zimmer Biomet (ZBH), had 2,785 restricted stock units (RSUs vest) converted into common shares on February 25, 2026. The Form 4 reports 2,785 shares acquired at $0.00 (code M — exercise/conversion of a derivative) and an equal 2,785-share disposition also at $0.00. No cash purchase price or dollar value is reported for the conversion.

Key Details

• Transaction date: February 25, 2026 (Form 4 filed Feb 27, 2026).
• Reported actions: 2,785 shares acquired (code M) at $0.00; 2,785 shares disposed (derivative) at $0.00.
• Price/value: $0.00 per share reported; no monetary value disclosed for the transaction.
• Shares owned after transaction: not specified in the provided filing details.
• Footnote: One‑third of the RSUs vested on Feb 25, 2026; remaining RSUs vest half on Feb 25, 2027 and half on Feb 25, 2028.
• Timeliness: Filing appears timely (Form 4 filed two days after the transaction date).

Context
Code M indicates an exercise or conversion of a derivative (here, RSU vesting/settlement). The equal acquired and disposed amounts commonly reflect net settlement or shares withheld/transferred to satisfy tax or withholding obligations, though the filing does not explicitly state the reason. This was not an open‑market purchase or sale signaling a directional bet by the insider; it appears to be routine vesting/settlement activity.